📇 Rhumatologue · LA TRONCHE · (38) · Hospitalier
Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
4 raisons identifiées
Encadrant universitaire
Forme la prochaine génération de rhumatologues (1 thèse dirigée)
Praticien-chercheur
13 articles scientifiques publiés — formation continue solide
Disponibilité géographique
2 lieux d'exercice — choisissez celui qui vous arrange
Délais de RDV courts dans la région
120.1 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Source theses.fr — signal de direction d'équipe / statut PU-PH (à confirmer via le site universitaire).
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
40
40 articles ont été cités au moins 40fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
5 964
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
363
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
129
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Affiliations FR : Inserm · Université Grenoble Alpes
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Perceptual Learning as a Rehabilitation Approach to Enhance Motion Processing in Maculopathy Patients
2026ArticleInvestigative Ophthalmology & Visual Science
Enhancing peripheral scene recognition through spatial frequency training: Behavioral evidence from macular degeneration and healthy aging
2026ArticleNeuropsychologia
Ophthalmotoxicology of polyhalogenated compounds
2026ArticleToxicology
Neurobehavioral Changes in Macular Degeneration: Spatial Frequency Use in Scene Recognition
2025ArticleInvestigative Ophthalmology & Visual Science
Changes in Retinal Vasculature Phenotype and Choroidal Blood Flow at High Altitude in Healthy Lowlanders
2025ArticleInvestigative Ophthalmology & Visual Science
Comparison of subconjunctival TRIamcinolone acetonide injection and intravitreal dexamethasone (OZurdex) injection for uveitic and postoperative macular oedema: the TRIOZ study
2025ArticleBritish Journal of Ophthalmology
Motion-selective cortical network is preserved in maculopathy patients
2025CongrèsGDR Vision
A case-control study of peripapillary microvascular structure by OCT-angiography in non-arteritic ischaemic optic neuropathy at early and resolutive stages
2025ArticleEye
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
HOPITAL NORD - CHU38
BD DE LA CHANTOURNE, 38700 LA TRONCHE
CABINET PRIVE DU DR CHRISTOPHE CHIQUET
POLE OPHTALMOLOGIE HOPITAL NORD MICHALLON BOULEVARD DE LA CHANTOURNE, 38700 LA TRONCHE
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
The New England journal of medicine · 2020
American journal of hematology · 2021
AbstractThe treatment of primary vitreoretinal lymphoma (PVRL) remains controversial regarding the use of local, systemic, or combined treatments. The aim of this study was to analyze the efficacy and toxicity of intravenous high‐dose methotrexate (IV HD‐MTX) based systemic therapy in a uniformly treated population of PVRL patients. From a nationwide French database, we retrospectively selected 59 patients (median age: 70 years, median Karnofsky Performance Status: 90%) with isolated PVRL at diagnosis who received first‐line treatment with HD‐MTX between 2011 and 2018. 8/59 patients also received a local treatment. No deaths or premature discontinuations of MTX due to toxicity were reported. A complete response was obtained in 40/57 patients after chemotherapy. Before treatment, IL‐10 was elevated in the aqueous humor (AH) or in the vitreous in 89% of patients. After treatment, AH IL‐10 was undetectable in 87% of patients with a CR/uCR/PR and detectable in 92% of patients with PD/SD. After a median follow‐up of 61 months, 42/59 (71%) patients had relapsed, including 29 isolated ocular relapses as the first relapse and a total of 22 brain relapses. The median overall survival, progression‐free survival, ocular‐free survival and brain‐free survival were 75, 18, 29 and 73 months, respectively. IV HD‐MTX based systemic therapy as a first‐line treatment for isolated PVRL is feasible, with acceptable toxicity, even in an elderly population. This strategy seems efficient to prevent brain relapse with prolonged overall survival. However, the ocular relapse rate remains high. New approaches are needed to improve local control of this disease, and ocular assessment could be completed by monitoring AH IL‐10.
Journal of personalized medicine · 2024
Purpose: To evaluate the safety and efficacy of the fluocinolone acetonide implant (FAi, Iluvien® Horus pharma, Nice, France) in non-infectious uveitic macular edema (UME) and to approach the predictive factors of treatment response. Methods: This retrospective, multicenter real-life study included patients with chronic non-infectious UME who received intravitreal FAi after at least two dexamethasone implants (DEXi). Results: Twenty-six eyes from 22 patients (73.1% of females) were included. The mean age was 60.4 ± 16 years. The mean follow-up was 11.4 ± 2 months. The mean baseline best-corrected visual acuity (BCVA) was 0.43 ± 0.36 LogMAR, improving significantly after 1, 3, 6 and 12 months (all p < 0.05 vs. baseline). The mean baseline central macular thickness (CMT) was 429 ± 110 μm, improving significantly after 1, 3, 6 and 12 months (all p < 0.05 vs. baseline). Five eyes (19.2%) developed ocular hypertension during the follow-up, requiring initiation or strengthening of intraocular pressure lowering medication. The majority of eyes (77%) did not require any rescue DEXi during the available 12-month follow-up. The resolution of UME after DEXi seemed to predict the anatomical response after FAi. The baseline presence of a disorganization of the inner retinal layers (DRIL) and hyperreflective foci (HRF) were both associated with a higher likelihood of requiring rescue DEXi injections. Conclusion: FAi implantation led to a significant BCVA and CMT improvement with a good safety profile over the 12-month follow-up. Predictive factors of treatment outcomes seem to include the anatomical response to DEXi and the presence of DRIL and HRF at baseline.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Scientific reports · 2026 · Journal Article
Amiot V, Pulvirenti R, Jimenez-Del-Toro O, Ott M, et al.
Therapie · 2026 · Letter
Blanc A, Khouri C, Bouillet L, Chiquet C
Frontiers in medicine · 2026 · Journal Article
Bord A, Bourcier T, Hirsch AL, Gallice M, et al.
Computers in biology and medicine · 2025 · Journal Article
Amiot V, Jimenez-Del-Toro O, Guex-Crosier Y, Ott M, et al.
Retinal cases & brief reports · 2025 · Journal Article
Bec L, Khouri C, Chiquet C
Autoimmunity reviews · 2021 · Letter
Coste N, Bocquet A, Labarere J, Semecas R, et al.
American journal of hematology · 2021 · Journal Article
Lam M, Touitou V, Choquet S, Cassoux N, et al.
Retina (Philadelphia, Pa.) · 2021 · Journal Article
Kosacki J, Gallice M, Palombi K, Labarere J, et al.
Trials · 2022 · Clinical Trial Protocol
Chiquet C, Vignal C, Gohier P, Heron E, et al.
The New England journal of medicine · 2020 · Journal Article
Milea D, Najjar RP, Zhubo J, Ting D, et al.
Journal of epidemiology and population health · 2024 · Journal Article
Prevel M, Boussat B, Bouisse M, Robert PY, et al.
Journal of personalized medicine · 2024 · Journal Article
Jabbour M, Kodjikian L, Bourdin A, Rougier MB, et al.
Scientific reports · 2024 · Journal Article
Bec L, Herber R, Bailly S, Van Ngo TH, et al.
Measurement of Absolute Retinal Blood Flow Using a Laser Doppler Velocimeter Combined with Adaptive Optics
<strong>Data set of measurements related to the following:</strong> <strong>Purpose: </strong>Development and validation of an absolute laser Doppler velocimeter (LDV) based on an adaptive optical fundus camera which pro
Measurement of Absolute Retinal Blood Flow Using a Laser Doppler Velocimeter Combined with Adaptive Optics
<strong>Data set of measurements related to the following:</strong> <strong>Purpose: </strong>Development and validation of an absolute laser Doppler velocimeter (LDV) based on an adaptive optical fundus camera which pro
Measurement of Absolute Retinal Blood Flow Using a Laser Doppler Velocimeter Combined with Adaptive Optics
<strong>Purpose</strong>: Development and validation of an absolute laser Doppler velocimeter (LDV) based on an adaptive optical fundus camera which provides simultaneously high definition images of the fundus vessels an
Intraocular Cytokine Levels in Post-Cataract Endophthalmitis and their Association with Visual Outcome
<i>Purpose</i>: The host immune reaction during endophthalmitis, studied in particular through the intraocular cytokine network, is essential for the comprehension of the disease and the development of new therapies. The
Intraocular Cytokine Levels in Post-Cataract Endophthalmitis and their Association with Visual Outcome
<i>Purpose</i>: The host immune reaction during endophthalmitis, studied in particular through the intraocular cytokine network, is essential for the comprehension of the disease and the development of new therapies. The
Measurement of Absolute Retinal Blood Flow Using a Laser Doppler Velocimeter Combined with Adaptive Optics
<strong>Purpose</strong>: Development and validation of an absolute laser Doppler velocimeter (LDV) based on an adaptive optical fundus camera which provides simultaneously high definition images of the fundus vessels an
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).